ALSO IN THIS MONTH'S ISSUE
-
My Journey From "Science Guy" To CEO
I am a big believer in refining one's personal brand and even reinventing yourself to create opportunities for personal growth. During my career, some key truths and learnings have emerged that I feel privileged to share, and I hope these will be insightful and helpful.
-
Persistent Noncompliance Leads To A Consent Decree
What happens when failures are discovered repeatedly during FDA inspections, even after the company has been warned to correct them?
-
Why Life Sciences Change-Management Initiatives Fail
Oftentimes companies excel at the technology and process elements of organizational change management but do not take into consideration the “people” part of this important triad.
-
Companies To Watch: Corner Therapeutics
Corner Therapeutics is focused on discovering new small molecules that could mimic the body’s natural immune response to generate the robust T-cell response.
WEB-EXCLUSIVE EDITORIAL
NEWSLETTER ARCHIVE
- 02.03.23 -- Why Corner Therapeutics Is Our Company To Watch
- 02.02.23 -- Maximizing Cell Culture Productivity
- 02.02.23 -- AAV Development And Manufacturing: Practical And Innovative Solutions
- 02.01.23 -- Why Takeda Is Focusing So Much On Plasma-Derived Therapies
- 02.01.23 -- Ensuring Success In Early Biopharma Formulation Development
LIFE SCIENCE LEADER CONTENT COLLECTIONS
ASK THE BOARD
- What Tips Would You Give To An Early-Stage Biopharma CEO Preparing To Present New Clinical Data At A Medical Meeting?
- Do You Think That Biopharmaceutical Companies Receiving An FDA Accelerated Approval Should Be Required To Enroll Patients In A Confirmatory Study Prior To Launch?
- What Key Characteristics Or Attributes — Beyond Functional Or Scientific Expertise — Should A CEO Look For In Considering The Addition Of A New Board Member?
@LIFESCILEADER1
This website uses cookies to ensure you get the best experience on our website. Learn more